Skip to main content
SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. logo

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603231 ISIN · CNE100006DV2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2023-11-23 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603231

About SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD.

https://www.solbar.com/

SOLBAR NINGBO PROTEIN TECHNOLOGY CO., LTD. is a specialized manufacturer of high-quality soy protein ingredients. The company produces a comprehensive range of products, including soy protein isolates, functional concentrates, textured soy proteins, and soy fibers. These ingredients are utilized extensively in the global food and beverage sectors, serving applications in meat processing, plant-based alternatives, nutritional supplements, and bakery products. The company emphasizes the use of non-GMO raw materials and advanced processing technologies to ensure high functionality and nutritional value. Its operations focus on delivering consistent quality and technical support to meet the evolving demands of the health-conscious consumer market and industrial food production.

Recent filings

Filing Released Lang Actions
索宝蛋白首次公开发行股票并在主板上市发行安排及初步询价公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Ningbo Suobao Protein Technology Co., Ltd., including issuance arrangements, preliminary inquiry, investor qualifications, pricing methods, subscription limits, and timelines. It references regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange rules. The content focuses on the IPO process, subscription details, investor eligibility, and issuance schedule, without presenting financial statements or earnings data. It is not a financial report like an Annual Report or Interim Report, nor is it a transcript, audit report, or management change announcement. It is a formal issuance and capital raising announcement related to the company's stock issuance and listing. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the announcement itself, not a brief report publication notice.
2023-11-23 Chinese
索宝蛋白首次公开发行股票并在主板上市招股意向书
Capital/Financing Update Classification · 95% confidence The document is titled as a "招股意向书" which translates to "Prospectus" or "Offering Intention Document" for the company's initial public offering (IPO) and listing on the main board. It contains detailed information about the stock issuance, underwriting, company background, risk factors, financial data, governance, and other disclosures typical of an IPO prospectus. This is not an annual report, earnings release, or any other type of periodic financial report. It is a detailed offering document related to capital raising and stock issuance. According to the filing definitions, this fits best under Capital/Financing Update (CAP) as it relates to company fundraising and issuance of new shares for public listing.
2023-11-23 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.